IGHE and leukemia: According to Morikawa et al. (2018), compound 3 inhibited the release of β-hexosaminidase, a biomarker of the anti-allergic activity through antigen-IgE-stimulated degranulation in rat basophilic leukemia cells (RBL-2H3) (Table 9).